[1]
J. Aliaga-Caján, J. Caballero-Alvarado, R. Sandoval-Ato, J. Barboza-Meca, and V. Serna-Alarcón, “Target therapies plus chemotherapy compared to chemotherapy in Stage IV or recurrent triple negative breast cancer. A Systematic Review and Meta-analysis”, Rev. Cuerpo Med. HNAAA, vol. 14, no. 2, pp. 163–172, Aug. 2021.